Published in Ann N Y Acad Sci on July 01, 2006
Food insecurity and chronic disease. Adv Nutr (2013) 1.17
Persistence of maternal effects in baboons: Mother's dominance rank at son's conception predicts stress hormone levels in subadult males. Horm Behav (2008) 1.10
Early-life experience, epigenetics, and the developing brain. Neuropsychopharmacology (2014) 1.00
Epigenetic influence of stress and the social environment. ILAR J (2012) 0.99
Adaptive significance of natural variations in maternal care in rats: a translational perspective. Neurosci Biobehav Rev (2011) 0.95
Neurobiology of Maternal Stress: Role of Social Rank and Central Oxytocin in Hypothalamic-Pituitary Adrenal Axis Modulation. Front Psychiatry (2015) 0.75
Early Life Stress, Mood, and Anxiety Disorders. Chronic Stress (Thousand Oaks) (2017) 0.75
Maternal hypothalamic-pituitary-adrenal axis response to foraging uncertainty: A model of individual vs. social allostasis and the "Superorganism Hypothesis". PLoS One (2017) 0.75
Association of FKBP5 polymorphisms and childhood abuse with risk of posttraumatic stress disorder symptoms in adults. JAMA (2008) 6.60
Antidepressant efficacy of ketamine in treatment-resistant major depression: a two-site randomized controlled trial. Am J Psychiatry (2013) 4.84
Mood disorders in the medically ill: scientific review and recommendations. Biol Psychiatry (2005) 4.81
Allele-specific FKBP5 DNA demethylation mediates gene-childhood trauma interactions. Nat Neurosci (2012) 4.71
Influence of child abuse on adult depression: moderation by the corticotropin-releasing hormone receptor gene. Arch Gen Psychiatry (2008) 4.65
The role of dopamine in the pathophysiology of depression. Arch Gen Psychiatry (2007) 4.51
The efficacy of light therapy in the treatment of mood disorders: a review and meta-analysis of the evidence. Am J Psychiatry (2005) 4.45
The link between childhood trauma and depression: insights from HPA axis studies in humans. Psychoneuroendocrinology (2008) 4.35
Binge eating as a major phenotype of melanocortin 4 receptor gene mutations. N Engl J Med (2003) 4.07
Safety and efficacy of repeated-dose intravenous ketamine for treatment-resistant depression. Biol Psychiatry (2010) 4.00
Effects of pulse width and electrode placement on the efficacy and cognitive effects of electroconvulsive therapy. Brain Stimul (2008) 3.50
Increased stress-induced inflammatory responses in male patients with major depression and increased early life stress. Am J Psychiatry (2006) 3.33
Are mood disorders and obesity related? A review for the mental health professional. J Clin Psychiatry (2004) 3.26
Neurobehavioral effects of interferon-alpha in cancer patients: phenomenology and paroxetine responsiveness of symptom dimensions. Neuropsychopharmacology (2002) 3.24
Treatment of mood disorders. Nat Neurosci (2002) 3.13
Childhood trauma associated with smaller hippocampal volume in women with major depression. Am J Psychiatry (2002) 3.05
Effects of intravenous ketamine on explicit and implicit measures of suicidality in treatment-resistant depression. Biol Psychiatry (2009) 3.04
Early life programming and neurodevelopmental disorders. Biol Psychiatry (2010) 2.93
Prolonged institutional rearing is associated with atypically large amygdala volume and difficulties in emotion regulation. Dev Sci (2010) 2.79
Prefrontal dopamine D1 receptors and working memory in schizophrenia. J Neurosci (2002) 2.69
Rapid and longer-term antidepressant effects of repeated ketamine infusions in treatment-resistant major depression. Biol Psychiatry (2012) 2.69
Depressive symptoms and viral clearance in patients receiving interferon-alpha and ribavirin for hepatitis C. Brain Behav Immun (2005) 2.52
Long-term consequences of neonatal rearing on central corticotropin-releasing factor systems in adult male rat offspring. Neuropsychopharmacology (2005) 2.35
Reduced glucocorticoid receptors: consequence or cause of depression? Trends Endocrinol Metab (2006) 2.26
Elevated maternal interleukin-8 levels and risk of schizophrenia in adult offspring. Am J Psychiatry (2004) 2.23
Ketamine for depression: where do we go from here? Biol Psychiatry (2012) 2.21
Adipose tissue quantification by imaging methods: a proposed classification. Obes Res (2003) 2.19
Neurobiological and psychiatric consequences of child abuse and neglect. Dev Psychobiol (2010) 2.17
Depression, desperation, and suicidal ideation in college students: results from the American Foundation for Suicide Prevention College Screening Project at Emory University. Depress Anxiety (2008) 2.16
Epidemiology of comorbid coronary artery disease and depression. Biol Psychiatry (2003) 2.13
Interferon-alpha-induced changes in tryptophan metabolism. relationship to depression and paroxetine treatment. Biol Psychiatry (2003) 2.05
Importance of studying the contributions of early adverse experience to neurobiological findings in depression. Neuropsychopharmacology (2004) 2.03
Feasibility of near-infrared spectroscopic tomography for intraoperative functional cerebral monitoring: a primate study. J Thorac Cardiovasc Surg (2014) 2.02
The role of executive functioning in CBT: a pilot study with anxious older adults. Behav Res Ther (2005) 1.97
Adverse effect of paroxetine on sperm. Fertil Steril (2009) 1.90
Association of exaggerated HPA axis response to the initial injection of interferon-alpha with development of depression during interferon-alpha therapy. Am J Psychiatry (2003) 1.90
Anterior cingulate activation and error processing during interferon-alpha treatment. Biol Psychiatry (2005) 1.80
Long-term behavioural and molecular alterations associated with maternal separation in rats. Eur J Neurosci (2007) 1.79
Increased hippocampal plaques and tangles in patients with Alzheimer disease with a lifetime history of major depression. Arch Gen Psychiatry (2006) 1.79
Self-report-based estimates of energy intake offer an inadequate basis for scientific conclusions. Am J Clin Nutr (2013) 1.79
Puberty, ovarian steroids, and stress. Ann N Y Acad Sci (2004) 1.79
The relationship of depression and diabetes: pathophysiological and treatment implications. Psychoneuroendocrinology (2011) 1.74
The role of early adverse experience and adulthood stress in the prediction of neuroendocrine stress reactivity in women: a multiple regression analysis. Depress Anxiety (2002) 1.72
The dexamethasone/corticotropin-releasing factor test in men with major depression: role of childhood trauma. Biol Psychiatry (2007) 1.71
Catechol-O-methyltransferase (COMT) genotypes and working memory: associations with differing cognitive operations. Biol Psychiatry (2005) 1.71
The variable number of tandem repeats element in DAT1 regulates in vitro dopamine transporter density. BMC Genet (2005) 1.70
Paternal age and risk of schizophrenia in adult offspring. Am J Psychiatry (2002) 1.69
Modulation of vigilance in the primary hypersomnias by endogenous enhancement of GABAA receptors. Sci Transl Med (2012) 1.68
Alterations in diurnal cortisol rhythm and acoustic startle response in nonhuman primates with adverse rearing. Biol Psychiatry (2005) 1.65
Does psychosocial functioning improve independent of depressive symptoms? A comparison of nefazodone, psychotherapy, and their combination. Biol Psychiatry (2002) 1.65
Basal ganglia hypermetabolism and symptoms of fatigue during interferon-alpha therapy. Neuropsychopharmacology (2007) 1.63
Hypercortisolemia and depression. Psychosom Med (2005) 1.60
Long-term adaptations in glucocorticoid receptor and mineralocorticoid receptor mRNA and negative feedback on the hypothalamo-pituitary-adrenal axis following neonatal maternal separation. Biol Psychiatry (2004) 1.59
Effects of risperidone augmentation in patients with treatment-resistant depression: Results of open-label treatment followed by double-blind continuation. Neuropsychopharmacology (2006) 1.59
The selective serotonin reuptake inhibitor citalopram increases fear after acute treatment but reduces fear with chronic treatment: a comparison with tianeptine. Biol Psychiatry (2004) 1.59
Depression during pegylated interferon-alpha plus ribavirin therapy: prevalence and prediction. J Clin Psychiatry (2005) 1.58
The NF-kappaB/IkappaB signaling system: a molecular target in breast cancer therapy. J Surg Res (2005) 1.58
Persistent pulmonary hypertension of the newborn and selective serotonin reuptake inhibitors: lessons from clinical and translational studies. Am J Psychiatry (2012) 1.56
A case of sustained remission following an acute course of ketamine in treatment-resistant depression. J Clin Psychiatry (2011) 1.55
Orbitofrontal cortex activity related to emotional processing changes across the menstrual cycle. Proc Natl Acad Sci U S A (2005) 1.55
The Prevention of Recurrent Episodes of Depression with Venlafaxine for Two Years (PREVENT) Study: Outcomes from the 2-year and combined maintenance phases. J Clin Psychiatry (2007) 1.54
Effects of interferon-alpha on rhesus monkeys: a nonhuman primate model of cytokine-induced depression. Biol Psychiatry (2007) 1.51
Resting neural activity distinguishes subgroups of schizophrenia patients. Biol Psychiatry (2004) 1.51
Tryptophan depletion and emotional processing in healthy volunteers at high risk for depression. Biol Psychiatry (2011) 1.51
Circulating endothelial progenitor cells in multiple myeloma: implications and significance. Blood (2004) 1.49
Neurobiological mechanisms in major depressive disorder. CMAJ (2009) 1.49
Hippocampal structural changes across the menstrual cycle. Hippocampus (2008) 1.49
Neurobiology of posttraumatic stress disorder. CNS Spectr (2009) 1.48
Self-reported depressive symptom measures: sensitivity to detecting change in a randomized, controlled trial of chronically depressed, nonpsychotic outpatients. Neuropsychopharmacology (2005) 1.47
International Study to Predict Optimized Treatment for Depression (iSPOT-D), a randomized clinical trial: rationale and protocol. Trials (2011) 1.46
Cellular response to hypoxia involves signaling via Smad proteins. Blood (2002) 1.45
Long-term experience with duodenal switch in adolescents. Obes Surg (2010) 1.44
Physiological models of body composition and human obesity. Nutr Metab (Lond) (2007) 1.43
Potential psychiatric applications of metabotropic glutamate receptor agonists and antagonists. CNS Drugs (2010) 1.43
Measuring the severity of depression and remission in primary care: validation of the HAMD-7 scale. CMAJ (2005) 1.42
Polymorphisms in CRHR1 and the serotonin transporter loci: gene x gene x environment interactions on depressive symptoms. Am J Med Genet B Neuropsychiatr Genet (2010) 1.42
Amino acid neurotransmitters assessed by proton magnetic resonance spectroscopy: relationship to treatment resistance in major depressive disorder. Biol Psychiatry (2008) 1.42
Effect of Childhood Trauma on Adult Depression and Neuroendocrine Function: Sex-Specific Moderation by CRH Receptor 1 Gene. Front Behav Neurosci (2009) 1.41
Cerebrospinal fluid corticotropin-releasing factor and perceived early-life stress in depressed patients and healthy control subjects. Neuropsychopharmacology (2004) 1.41
Neuropsychological differences between late-onset and recurrent geriatric major depression. Am J Psychiatry (2005) 1.41
Global benefit-risk assessment of antidepressants: venlafaxine XR and fluoxetine. J Psychiatr Res (2002) 1.40
Prevention of recurrent episodes of depression with venlafaxine ER in a 1-year maintenance phase from the PREVENT Study. J Clin Psychiatry (2007) 1.40
Facial expressiveness in patients with schizophrenia compared to depressed patients and nonpatient comparison subjects. Am J Psychiatry (2005) 1.39
Atypical antipsychotic administration during late pregnancy: placental passage and obstetrical outcomes. Am J Psychiatry (2007) 1.38
Neurobiology of early life stress: clinical studies. Semin Clin Neuropsychiatry (2002) 1.38
Toward a functional neuroanatomy of premenstrual dysphoric disorder. J Affect Disord (2007) 1.33
Milnacipran: a comparative analysis of human monoamine uptake and transporter binding affinity. Biol Psychiatry (2004) 1.32
National Depressive and Manic-Depressive Association consensus statement on the use of placebo in clinical trials of mood disorders. Arch Gen Psychiatry (2002) 1.29
Parental depression: animal models of an adverse life event. Am J Psychiatry (2002) 1.29
Differential methylation in glucoregulatory genes of offspring born before vs. after maternal gastrointestinal bypass surgery. Proc Natl Acad Sci U S A (2013) 1.28
Pituitary-adrenal responses to standard and low-dose dexamethasone suppression tests in adult survivors of child abuse. Biol Psychiatry (2004) 1.26
Effects of ketamine on explicit and implicit suicidal cognition: a randomized controlled trial in treatment-resistant depression. Depress Anxiety (2014) 1.26
Depression, antidepressants, and neurogenesis: a critical reappraisal. Neuropsychopharmacology (2011) 1.25